Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Werewolf Therapeutics, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 73 | 1 | 70 | −2 |
| Shares | 28.2M | 73.4K | 27.4M | −658.3K (−2.3%) |
| Value | $41.7M | $108.6K | $26.7M | −$14.9M (−35.9%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AQR Capital Management LLC | 81,669 | $79.4K | 0.00% |
| Nuveen, LLC | 73,370 | $71.3K | 0.00% |
| Vontobel Holding Ltd. | 35,000 | $34.0K | 0.00% |
| Squarepoint Ops LLC | 11,828 | $11.5K | 0.00% |
| Ieq Capital, LLC | 10,837 | $10.5K | 0.00% |
| Rossby Financial, LCC | 860 | $766 | 0.00% |
| True Wealth Design, LLC | 22 | $22 | 0.00% |
Sold out (9)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| BIT Capital GmbH | 241,056 | $356.8K |
| Jane Street Group, LLC | 54,713 | $81.0K |
| Levin Capital Strategies, L.P. | 50,000 | $74.0K |
| American Century Companies Inc | 42,511 | $62.9K |
| XTX Topco Ltd | 24,905 | $36.9K |
| D. E. Shaw & Co., Inc. | 17,776 | $26.3K |
| SG Americas Securities, LLC | 13,779 | $20.0K |
| Two Sigma Securities, LLC | 12,740 | $18.9K |
| Nisa Investment Advisors, LLC | 40 | $59 |
Not filed for Q1 2025 yet (1)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 73,370 | $108.6K |